window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 7, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

outsourcing

  • Biotech & Pharma Business,Manufacturing & Supply Chain

    Aragen appoints Aniel Khubchandani to lead development and manufacturing solutions business

    Contract research, development and manufacturing organisation Aragen has appointed Aniel [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Therapeutic Areas

    Scientist.com expands AI-powered Tumor Model Finder with XenoSTART cancer models

    Scientist.com has expanded its AI-powered Tumor Model Finder through a [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain

    Solvias expands US cGMP testing capabilities with RTP center phase 2 build-out

    Solvias has achieved Current Good Manufacturing Practice (cGMP) readiness at [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data

    Clinical trial innovation hampered by change fatigue and skills gaps, survey finds

    A new survey from eClinical Solutions reveals that biopharma organizations [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • FDA backs Telix Phase 3 ProstACT trial expansion into US
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development
  • Hansa completes €115M Idefirix licensing deal with SERB
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics
  • Remepy study links Hybridopa brain changes to improved Parkinson’s outcomes
    Categories: Clinical & Regulatory, Digital & Data, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top